RNA aggregates harness the danger response for potent cancer immunotherapy

HR Mendez-Gomez, A DeVries, P Castillo… - Cell, 2024 - cell.com
Cancer immunotherapy remains limited by poor antigenicity and a regulatory tumor
microenvironment (TME). Here, we create" onion-like" multi-lamellar RNA lipid particle …